STAT3 and hepatocellular carcinoma: By stimulating ROS‐mediated MAPK, STAT3, and NF‐B signaling pathways, calycosin inhibited the expression of TGF‐1, SMAD2/3, SLUG, and vimentin and resisted hepatocellular cancer.76